Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alamar BiosciencesALMR +4.84%8 Gross Margin % is 56.20% as of Dec. 2025, which is 24% above its 10-year median of 45.22. GuruFocus rates ALMR with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 806 Medical Devices & Instruments companies, Alamar Biosciences ranks better than 56.7% on this metric.
The historical rank and industry rank for Alamar Biosciences's Gross Margin % or its related term are showing as below:
ALMR'
s Gross Margin % Range Over the Past 10 Years
Min: 34.23 Med: 45.22 Max: 56.2
Current: 56.2
During the past 2 years, the highestGross Margin % of Alamar Biosciences was 56.20%. The lowest was 34.23%. And the median was 45.22%.
ALMR's Gross Margin % is ranked better than 56.7% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs ALMR: 56.20
Alamar Biosciences had a gross margin of 56.20% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Alamar Biosciences was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Alamar Biosciences had a gross margin of 56.20% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Alamar Biosciences Gross Margin % Related Terms
Alamar Biosciences Gross Margin % Historical Data
* Premium members only.
The historical data trend for Alamar Biosciences's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alamar Biosciences Gross Margin % Chart
Alamar Biosciences Annual Data
Trend
Dec24
Dec25
Gross Margin %
34.23
56.20
Alamar Biosciences Semi-Annual Data
Dec24
Dec25
Gross Margin %
34.23
56.20
ALMR vs UFPT, BFLY, ENOV: Gross Margin % Comparison
For the Medical Devices subindustry, Alamar Biosciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alamar Biosciences Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alamar Biosciences's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Alamar Biosciences's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Alamar Biosciences (ALMR) has a Gross Margin % of 56.20% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Alamar Biosciences and its competitors. This is 24% above median its historical median of 45.22. Over the past decade, Alamar Biosciences' Gross Margin % has ranged from 34.23 to 56.20. According to the industry distribution chart, Alamar Biosciences ranks #349 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 43.3%.
Is Alamar Biosciences' Gross Margin % too high?
Alamar Biosciences' current Gross Margin % of 56.20% is 24% above median its 10-year median of 45.22. Over the past 10 years, this metric has ranged from a low of 34.23 to a high of 56.20. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Alamar Biosciences' value of 56.20% is 7.8% above this industry median. Based on the distribution chart, Alamar Biosciences ranks #349 out of 806 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Alamar Biosciences has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Alamar Biosciences' Gross Margin % compare to UFPT and BFLY?
According to the Medical Devices & Instruments industry distribution chart, Alamar Biosciences ranks #349 out of 806 companies for Gross Margin %. This puts Alamar Biosciences in the upper half of its industry. The industry median Gross Margin % is 52.12. Alamar Biosciences' value of 56.20% is 7.8% above this benchmark. Historically, Alamar Biosciences' own Gross Margin % has ranged from 34.23 to 56.20 over the past decade. While the company's 10-year median is 45.22 vs. the industry median of 52.12, Alamar Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alamar Biosciences's current Gross Margin % of 56.20% is 7.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Alamar Biosciences and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alamar Biosciences's current Gross Margin % is 56.20%, which is 24% above median its own 10-year median of 45.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alamar Biosciences stock overvalued right now?
Alamar Biosciences (ALMR) has a current Gross Margin % of 56.20%. The current Gross Margin % is 56.20%, which is 24% above median its 10-year median of 45.22 and 7.8% above the Medical Devices & Instruments industry median of 52.12. Alamar Biosciences' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Alamar Biosciences (ALMR), the current Gross Margin % is 56.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
8GF Score
Get the complete analysis for ALMR
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALMR has been successfully added to your 
